Skip to main content
. 2003 Jan 9;100(2):443–448. doi: 10.1073/pnas.2436191100

Table 2.

Phosphorylated peptides from BCR/ABL-expressing cells treated with STI571

Protein NCBI GI no. Peptide sequence PO4 site Known PO4 site (ref.) Top scansite hits (24) 0 hr 1.5 hr 3 hr
32d p210
 ABL 125135 LMTGDTpYTAHAGAK Y393 Y393 (43) None x NA
 ABL 125135 LMTGDTpYpTAHAGAK Y393, T394 Y393 (43) Y393:None,Y394:None x NA
 ABL 125135 LpYVSSESR Y185 None x x NA
 ABL 125135 pYSLTVAVK Y264 Y264 (44) None x NA
 ABL 125135 NKPTVpYGVSPNYDK Y226 Y226 (43) B-3.3,X-3.4,HH-2.5 x NA
 ABL 125135 VpYELMR Y469 AA-0.25,GG-2.8,II-3.3 x NA
 BCR 11038641 HQDGLPYIDDpSPSSpSPHLSSK S459, S463 S459:M-4.0,R-0.56,S463:G-1.3,H-1.6,R-0.32 x NA
 CAS-L 8567380 LpYQVPNSQAASR Y91 B-1.5,C-1.0,J-0.56 x x NA
 CAS-L 8567380 DVpYDVPPSHSTQGVpYDIPPS SVK Y176, Y188 Y176:C-0.14,J-0.01,Z-0.04 Y188:C-0.20,J-0.01,Z-0.03 x NA
 CBL 115857 IKPSSSANAIpYSLAAR Y655 Y655 (39) B-2.2 x x NA
 CBL 115857 LPPGEQGEpSEEDTEpYMTPTS RPVGVQKPEPK S675, Y681 Y681 (45) (Y700) S675:E-3.6,F-0.40,K-1.8 Y681:J-0.08,W-0.04,Z-0.06 x x NA
 DYRK1A 6015042 IYQpYIQSR Y321 Y321 (46) None x NA
 SHEP1 7305329 AGESpYTHIR Y273 None x NA
 SHP-2 6755228 VpYENVGLMQQQR Y584 Y584 (47) O-0.55,Y-1.9,JJ-1.9 x NA
k562
 ABL 125135 LMTGDTpYTAHAGAK Y393 Y393 (43) None x x
 ABL 125135 LMTGDTpYpTAHAGAK Y393, T394 Y393 (43) Y393:None,Y394:None x x
 ABL 125135 LpYVSSESR Y185 None x x
 ABL 125135 LGGGQpYGEVYEGVWK Y253 N-4.0,P-4.0,X-0.20 x
 ABL 125135 LGGGQYGEVpYEGVWK Y257 X-0.32,Y-0.65,II-0.83 x
 Activated p21cdc42Hs 18553914 pYATPQVIQAPGPR Y827 J-4.6,W-3.0 x
 Activated p21cdc42Hs 423137 VSSTHpYpYLLPERPSYLER Y912, Y913 Y912:BB-1.2,GG-2.1,HH-0.04 Y913:C-3.9,J-3.4,DD-1.3 x
 BCR 11038641 PFpYVNVEFHHER Y177 Y177 (30) N-2.7,Q-0.03,BB-3.2 x
 BCR 11038641 HQDGLPYIDDpSPSSpSPHLSSK S459, S463 S459:M-4.0,R-0.56,S463:G-1.3,H-1.6,R-0.32 x x
 BCR 11038641 RLpTWPR T310 A-2.4,D-1.9,EE-0.55 x x
 BCR 11038641 NSLETLLpYKPVDR Y644 None x
 BCR 11038641 LASQLGVpYR Y591 None x
 CBL 115855 IKPSSpSANAIpYSLAAR S669, Y674 Y674 (39) Y674:B-2.2,S669:None x
 CBL 115855 IKPSSSANAIpYSLAAR Y674 Y674 (39) B-2.2 x
 Cortactin 4885205 LPSSPVpYEDAASFK Y421 Y421 (48) O-1.6,Y-1.3,AA-2.0 x
 DNABP1 4557447 ELEEIpYMLPR Y1068 B-0.37,W-0.66,DD-1.3 x
 e3b1 2245671 HNSTTSSTSSGGpYR Y305 None x
 GAB1 4503851 SYpSHDVLPK S266 D-0.82,E-3.6,I-4.2 x
 GAB1 4503851 APSASVDSSLpYNLPR Y259 C-2.8,J-0.76,Z-2.1 x x x
 GAB2 18105042 HNTEFRDSTpYDLPR Y266 C-0.65,J-0.56,Z-0.22 x
 GAGE-3 4503881 STpYYWPRPR Y10 B-0.59,C-1.3,J-2.9 x
 p56dok 4503359 GQEGEpYAVPFDAVAR Y299 B-0.04,W-0.66,X-0.67 x
 p62dok 4503357 SHNSALpYSQVQK Y449 P-3.0 x
 plakophilin 4 4505843 NNYALNTTATpYAEPpYRPIQYR Y478, Y482 Y478:B-0.02,C-0.52,W-1.0,Y482:None x
 SHC 284403 ELFDDPSpYVNVQNLDK Y317 Y317 (49) L-0.47,Q-0.01,BB-0.33 x
 SHIP-2 4755142 TLSEVDpYAPAGPAR Y1135 W-4.3 x x x
 SHIP-2 4755142 GLPSDpYGR(PLSFPPPR) Y1162 Y1162 (39) B-0.60,J-0.96,C-2.8 x x
 SHIP-2 4755142 DTpYAWHK Y671 None x
 SHIP-2 4755142 LpYEWISIDKDEAGAK Y886 P-1.1,W-1.5,GG-0.52 x
 SHIP-2 4755142 NSFNNPApYYVLEGVPHQLLPP EPPpSPAR Y986, S994 Y986 (50) Y986:L-0.20,N-1.7,FF-0.19,S994:None x
 SYK 1174527 EALPMDTEVpYESPpYADPEEIR PK Y348, Y352 Y348, Y352 (51) Y348:C-0.65,W-0.07,Z-0.22 Y352:C-1.9,W-0.18,BB-3.2 x

Times are after STI571 treatment. Scansite motifs are described in Table 1. NA, time points not analyzed in the experiments.